Cargando…
Low humoral immune response to the BNT162b2 vaccine against COVID-19 in nursing home residents undergoing hemodialysis: a case–control observational study
BACKGROUND: Patients on hemodialysis (HD) face a high mortality risk from coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and they are therefore prioritized for vaccination. However, the efficacy of vaccination in this vulnerable populatio...
Autores principales: | Kitamura, Mineaki, Takazono, Takahiro, Yamamoto, Kazuko, Harada, Takashi, Funakoshi, Satoshi, Mukae, Hiroshi, Nishino, Tomoya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924726/ https://www.ncbi.nlm.nih.gov/pubmed/35308296 http://dx.doi.org/10.1186/s41100-022-00397-5 |
Ejemplares similares
-
Favorable Humoral Response to Third Dose of BNT162b2 in Patients Undergoing Hemodialysis
por: Kitamura, Mineaki, et al.
Publicado: (2022) -
Association between the psoas muscle index and hospitalization for pneumonia in patients undergoing hemodialysis
por: Yamaguchi, Kosei, et al.
Publicado: (2021) -
The impact of muscle mass loss and deteriorating physical function on prognosis in patients receiving hemodialysis
por: Kitamura, Mineaki, et al.
Publicado: (2021) -
Long-Term Neutralizing Antibody Titers After BNT162b2 Vaccination in Hemodialysis Patients
por: Takazono, Takahiro, et al.
Publicado: (2023) -
Association between Serum Phosphate Levels and the Development of Aortic Stenosis in Patients Undergoing Hemodialysis
por: Torigoe, Miki, et al.
Publicado: (2021)